GILD Stock DD Gilead Sciences, Inc. 09/30/2014 20:49:35

New Post Public Reply Private Reply Replies (0) Message Board

Sep 30, 2014 at 9:49 PM

GILD Gilead Sciences, Inc. $GILD Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=GILD&...mp;yt0=Go!

Last Updated: 09/30/2014 20:49:30

Current Price and Quotes
Last Price
Previous Close Open
Daily Range - 52wk Range -
Volume Dividend
Average Vol (30d) Yield

Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 11,201,688 9,702,517 8,385,385 7,949,420
Cost of Revenue 2,858,502 2,471,363 2,124,410 1,869,876
Gross Profit 8,343,186 7,231,154 6,260,975 6,079,544
Operating Expenses

Research and Development 2,119,756 1,759,945 1,229,151 1,072,930
Sales, General and Admin. 1,699,431 1,461,034 1,241,983 1,044,392
Non-Recurring Items - - - -
Other - - - -
Operating Income 4,523,999 4,010,175 3,789,841 3,962,222
Income From Continuing Operations

Add'l Income/Expense Items (8,886) (37,279) 66,581 60,287
Earnings Before Interest and Tax 4,515,113 3,972,896 3,856,422 4,022,509
Interest Expense 306,894 360,916 205,418 108,961
Earnings Before Tax 4,208,219 3,611,980 3,651,004 3,913,548
Income Tax 1,150,933 1,038,381 861,945 1,023,799
Minority Interest (17,522) (17,967) (14,578) (11,508)
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 3,074,808 2,591,566 2,803,637 2,901,257
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 3,074,808 2,591,566 2,803,637 2,901,257
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 3,074,808 2,591,566 2,803,637 2,901,257

Recent News

Sep 30, 2014 Positive Study Results, Acquisitions, Drug Approval, Regulatory Updates, and Collaborations - Research Reports on Gilead, Pfizer, AbbVie, Pacira and Thermo Fisher
Sep 29, 2014 The Zacks Analyst Blog Highlights: Gilead Sciences, Bristol-Myers, Johnson & Johnson, AbbVie and Medivation
Sep 26, 2014 European CHMP Adopts Positive Opinion for Gilead's Harvoni(R) (Ledipasvir/Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection in Adults
Sep 25, 2014 The Medicines Patent Pool Adds New Sub-Licensing Agreements to Improve Access to Novel ARVs in Developing Countries
Sep 24, 2014 Critical Alerts For Gilead Sciences, Ambarella, American Capital Agency, NetApp and Ford Released By InvestorsObserver
Sep 24, 2014 Gilead's Investigational Tenofovir Alafenamide (TAF)-Based Single Tablet HIV Regimen Meets 48-Week Primary Objective in Two Phase 3 Studies
Sep 24, 2014 Gilead Submits New Drug Application to Japan's Pharmaceutical and Medical Devices Agency for Fixed-Dose Combination of Ledipasvir/Sofosbuvir for Chronic Hepatitis C Genotype 1 Infection
Sep 22, 2014 Licensing Agreements, Results of Clinical Trials, and Acquisitions - Research Reports on Gilead, AbbVie, Pfizer, Auxilium and Endo
Sep 22, 2014 Celladon Corporation Appoints Scott Garrett Vice President, Commercial Planning
Sep 19, 2014 Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent

1
2
3
4
5
6
next >

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KAPSARC Drives Energy Dialogue at WPC in Riyadh

Defining Energy Horizons in Riyadh Mark those calendars, because as the global energy crowd descends on Riyadh from October 11 to 15, 2026, KAPSARC steps into the spotlight. As the National Partner at the 25th World Petroleum Congress (WPC), they're not just warming the bench—they're playing every position, shaking up the field of energy. Paving the Pathways with...

Haag-Streit Debuts Innovative Octopus 910 Perimeter at AAO

Now here's something that'll tickle your ophthalmologist's fancy—Haag-Streit USA has rolled out the Octopus 910, a slick piece of kit set to shake up visual field testing for glaucoma management. This time, they're getting in front of the competition, unveiling it at the Association for Research in Vision and Ophthalmology's 2026 shindig in New Orleans. With this new...

Young Visionaries Win Junior Medals at STARMUS VIII

Fresh from the Canary Islands' shores, STARMUS VIII has lifted the veil on two young powerhouses shaping tomorrow—Valeria Corrales and Aneeshwar Kunchala. These two have snagged coveted honors, crowning them as champions of their generation. Igniting Passion for Science and the Environment Valeria Corrales isn't just another face in the crowd; she’s the force behind a...

Jiangxi Dialogues: Youths Forge Global Ties in 2026

Bringing Global Youth to the Table In the heart of Jiangxi, China, young minds from across the globe gathered not just to chat but to shape the future. A bunch who only a decade ago might have been ignored in such circles are now leading discussions, and they’ve kicked off their powwow on September 22, 2026, with a bang in Nanchang. What’s the Agenda? Imagine more...

Phoenix Scholar Examines AI and Institutional Trust

A Thoughtful Look at Trust and Technology We're staring at an issue here that dives deep into the guts of how technology, AI in particular, is reshaping our professional landscape. The latest issue of the Phoenix Scholar, a publication from the University of Phoenix College of Doctoral Studies, is tackling big questions. It's that kind of brainy reading where you untangle...

Zoomlion Boosts Mining Gear Amid Global Revenue Surge

An Ambitious Expansion Overhaul Alright, let's talk Zoomlion Heavy Industry Science & Technology Co., Ltd. They're not just making a splash; they're wading knee-deep into expanding their mining machinery operations and taking charge in international markets. You see, in the first half of 2026, this Chinese behemoth saw its mining machinery business skyrocket by over...

APsystems Unveils C&I Storage Solutions at SEF 2026

APsystems Puts the Spotlight on Advanced Storage Move over, traditional energy solutions—APsystems is stepping into the future with a bang at the Smart Energy Forum 2026 in Prague. Set your sights on the latest advancements in solar and energy storage solutions as the company unveils its comprehensive offerings. If you’re hanging around the PVA EXPO PRAHA on October...

Buying Land in Greeneville: Avoiding Costly Mistakes

Diving Headfirst into Raw Land Purchases Buying land isn't like your typical house flip in Greeneville, Tennessee. It's a whole different ballgame out there. You might think you're just purchasing a piece of Mother Earth, but you got to know there's more beneath the surface—quite literally—before you sign anything. You can go from a promising adventure to a...

RingConn Smart Ring Gains Key FDA 510(k) Clearance

FDA Clearance: A Major Step for RingConn In a space where every tiny gadget-maker is desperately clawing for a regulatory nod, RingConn—a venture born from Shenzhen Ninenovo Technology Limited—has snagged an FDA 510(k) clearance (Clearance No. K260490) for their wearable Smart Ring that measures blood oxygen levels non-invasively. October 10, 2026, marked the day when...

Kexing Biopharm Expands Global Reach at CPHI Milan

Kexing Biopharm's Showstopper Moment in Milan Call it a strategic blowout or just audacious timing—Kexing Biopharm's move at the CPHI Milan 2026 has painted a clear picture. From October 6th to 8th, Milan was the stage where Kexing rolled out its showcase, bragging about a pipeline that screams innovation and possibility. And let’s be honest, their timing couldn’t...